Literature DB >> 31622800

Phenotypic similarity for rare disease: Ciliopathy diagnoses and subtyping.

Xiaoyi Chen1, Nicolas Garcelon2, Antoine Neuraz3, Katy Billot4, Marc Lelarge5, Thomas Bonald6, Hugo Garcia4, Yoann Martin4, Vincent Benoit2, Marc Vincent2, Hassan Faour2, Maxime Douillet2, Stanislas Lyonnet7, Sophie Saunier4, Anita Burgun8.   

Abstract

Rare diseases are often hard and long to be diagnosed precisely, and most of them lack approved treatment. For some complex rare diseases, precision medicine approach is further required to stratify patients into homogeneous subgroups based on the clinical, biological or molecular features. In such situation, deep phenotyping of these patients and comparing their profiles based on subjacent similarities are thus essential to help fast and precise diagnoses and better understanding of pathophysiological processes in order to develop therapeutic solutions. In this article, we developed a new pipeline of using deep phenotyping to define patient similarity and applied it to ciliopathies, a group of rare and severe diseases caused by ciliary dysfunction. As a French national reference center for rare and undiagnosed diseases, the Necker-Enfants Malades Hospital (Necker Children's Hospital) hosts the Imagine Institute, a research institute focusing on genetic diseases. The clinical data warehouse contains on one hand EHR data, and on the other hand, clinical research data. The similarity metrics were computed on both data sources, and were evaluated with two tasks: diagnoses with EHRs and subtyping with ciliopathy specific research data. We obtained a precision of 0.767 in the top 30 most similar patients with diagnosed ciliopathies. Subtyping ciliopathy patients with phenotypic similarity showed concordances with expert knowledge. Similarity metrics applied to rare disease offer new perspectives in a translational context that may help to recruit patients for research, reduce the length of the diagnostic journey, and better understand the mechanisms of the disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ciliopathies; Deep phenotyping; Patient similarity; Phenotypic similarity; Rare disease

Year:  2019        PMID: 31622800     DOI: 10.1016/j.jbi.2019.103308

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  5 in total

1.  Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity.

Authors:  Nathan D Seligson; Jeremy L Warner; William S Dalton; David Martin; Robert S Miller; Debra Patt; Kenneth L Kehl; Matvey B Palchuk; Gil Alterovitz; Laura K Wiley; Ming Huang; Feichen Shen; Yanshan Wang; Khoa A Nguyen; Anthony F Wong; Funda Meric-Bernstam; Elmer V Bernstam; James L Chen
Journal:  J Am Med Inform Assoc       Date:  2020-11-01       Impact factor: 4.497

2.  Patient-Patient Similarity-Based Screening of a Clinical Data Warehouse to Support Ciliopathy Diagnosis.

Authors:  Xiaoyi Chen; Carole Faviez; Marc Vincent; Luis Briseño-Roa; Hassan Faour; Jean-Philippe Annereau; Stanislas Lyonnet; Mohamad Zaidan; Sophie Saunier; Nicolas Garcelon; Anita Burgun
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

3.  Having Multiple Renal Cysts in a Young Adult is not Always a Sign of Polycystic Kidney Disease.

Authors:  K Kaynar; S Kayıpmaz; A H Çebi; Ş Hüseynova
Journal:  Balkan J Med Genet       Date:  2022-06-05       Impact factor: 0.810

4.  Similarity-based health risk prediction using Domain Fusion and electronic health records data.

Authors:  Jia Guo; Chi Yuan; Ning Shang; Tian Zheng; Natalie A Bello; Krzysztof Kiryluk; Chunhua Weng; Shuang Wang
Journal:  J Biomed Inform       Date:  2021-02-19       Impact factor: 8.000

5.  Deep phenotyping: Embracing complexity and temporality-Towards scalability, portability, and interoperability.

Authors:  Chunhua Weng; Nigam H Shah; George Hripcsak
Journal:  J Biomed Inform       Date:  2020-04-23       Impact factor: 6.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.